Position in PHAT
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$4,003,721
-$1,045,991 QoQ
Shares Held
360,371
+18.4% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. PHAT ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in PHAT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,003,721 | 360,371 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $5,049,712 | 304,383 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,982,496 | 338,360 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,022,745 | 419,473 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,436,512 | 707,578 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,780,801 | 465,616 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,300,692 | 71,941 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $443,785 | 43,086 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $530,181 | 49,923 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $360,014 | 39,432 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $349,468 | 33,700 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $240,661 | 16,806 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $8,919 | 795 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,958 | 628 | Shares | Sole | 2022-11-10 | |
| 2021-12-31 | $26,141 | 1,329 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $23,661 | 699 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $108,060 | 2,877 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $88,265 | 2,657 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $50,384 | 1,374 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $137,465 | 4,177 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $165,635 | 6,415 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||